HD-OPM Archive
Topics › Insulin resistance & diabetes

Metformin is being tested for CVD, cancer, Alzheimer's and other conditions

Louis Nervegna · Nov 21, 2025 · ♥ 6 reactions · 15 comments · original Facebook post
Insulin resistance & diabetesAging & longevity
↻ This is a repost. The main version (highest ranked) is Metformin is being tested for CVD, cancer and Alzheimer's, but mechanisms are unclear · Mar 08, 2024.
AI summary & key facts

Louis shares a Medscape piece describing renewed academic interest and new trials of metformin beyond diabetes, including cancer, obesity, liver, cardiovascular, neurodegenerative and renal disease.

(no text — see the shared post below)

Research cited

Feb 27, 2024 — Metformin might protect against CVD, cancer, Alzheimer’s, and a number of other diseases.

In academia, there has been a recent resurgence of interest in metformin for these purposes, and several new trials have begun.

Quoted:

“Emerging evidence suggests the drug may be effective for a much broader range of conditions beyond managing high blood glucose, including various cancers, obesity, liver disease, cardiovascular, neurodegenerative, and renal diseases. As the evidence for diverse uses accumulates, many trials have launched, with researchers looking to expand metformin's indications and validate or explore new directions.”

“Collectively, these data raise the question: Is metformin a drug for all diseases? It remains unclear as to whether all of these putative beneficial effects are secondary to its actions as an antihyperglycemic and insulin-sensitizing drug, or result from other cellular actions, including inhibition of mTOR (mammalian target for rapamycin), or direct antiviral actions."

MedscapeIs Metformin a 'Drug for All Diseases'?Metformin, a staple of glucose management for decades, is now being studied for use in a wide range of diseases from carotid atherosclerosis to vitiligo.medscape.com

#metforminHD #agingHD #longevityHD

← newer: Insulin is not glucose: CGMs miss insulin, and red meat spikolder: Nature review: metformin slowed aging in monkeys →